Rheumatology Network's Top 5: FDA Approvals

Check out rheumatology's most groundbreaking FDA approvals of 2021!

Related Videos
Video 4 - "Suspecting Hypercortisolism in Patients With Resistant Diabetes"
Video 3 - "Barriers to Accessing New Anti-Diabetes Medications"
Daniel Gaudet, MD, PhD | Credit: American College of Cardiology
Jonathan Barratt, MD | Credit: IgA Nephropathy Foundation
Matthew Nudy, MD | Credit: Penn State College of Medicine
Advancing Brilaroxazine Research in Schizophrenia with Larry Ereshefsky, PharmD
Related Content
Demodex Mite Density Increases in Psoriasis Patients Treated with Biologic Therapy

Demodex Mite Density Increases in Psoriasis Patients Treated with Biologic Therapy

April 29th 2024
Article
2024 State of the Air: Record Highs in US Particle Pollution, with Dr. John Balmes

2024 State of the Air: Record Highs in US Particle Pollution, with John Balmes, MD

April 24th 2024
Podcast
FDA Approves Abbott's Novel Dissolvable Stent Therapy for Peripheral Artery Disease

FDA Approves Abbott's Novel Dissolvable Stent Therapy for Peripheral Artery Disease

April 29th 2024
Article
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.

Diabetes Dialogue: 2024 ACP Type 2 Diabetes Recommendations

April 19th 2024
Podcast
FDA Accepts Tapinarof Cream sNDA for Atopic Dermatitis Patients Aged 2 Years and Older

FDA Accepts Tapinarof Cream sNDA for Atopic Dermatitis Patients Aged 2 Years and Older

April 29th 2024
Article
Brief Mindfulness Intervention for Psoriasis Boosts Awareness, Not Skin Health

Brief Mindfulness Intervention for Psoriasis Boosts Awareness, Not Skin Health

April 29th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.